No registrations found.
ID
Source
Brief title
Health condition
Surgical oncology
Elderly
Sponsors and support
Intervention
Outcome measures
Primary outcome
- Primary endpoint will be 30 day morbidity and mortality.
Secondary outcome
- Secondary endpoints will be length of hospital stay and the number of additional specialists involved in patient care in the 30 days after surgery.
Background summary
-
Study objective
This study will be performed to test the predictive value of the GFI, the VES-13 and the timed “up and go” test compared to components of PACE in elderly patients of the age of 70 years and above undergoing surgery for a solid tumour.
Study design
Data will be collected preoperatively and up to 30 days postoperatively
Intervention
The combination of components of PACE, the timed “up and go” test, the VES-13 and the GFI will be administered to every patient within two weeks prior to the surgical procedure. This can be done by a nurse in the preoperative clinic and will take approximately 30 minutes.
Patient data will be recorded during the length of the hospital stay, the patient file will be used to retrieve these data.
Preoperative data:
- medication used
- living situation
- comorbidity
- nutritional status.
Perioperative data:
- type of surgery
- duration of anaesthesia
- blood loss
- length of hospital stay
- postoperative complications
- consultation by other specialist.
Follow up: at the postoperative visit to the outpatient clinic additional data on morbidity occurring during the first 30 days postoperatively can be recorded as well as any additional specialists that were involved in patient care in the first 30 postoperative days.
P.O. Box 30.001
B.L. Leeuwen, van
Groningen 9700 RB
The Netherlands
+31 (0)50 3612301
blvleeuwen@hetnet
P.O. Box 30.001
B.L. Leeuwen, van
Groningen 9700 RB
The Netherlands
+31 (0)50 3612301
blvleeuwen@hetnet
Inclusion criteria
- Patients aged >70 years undergoing elective surgery for a solid tumour under general anaesthesia will be included for this study.
- Patients will be stratified according to tumour localisation: intra cavity (e.g. colorectal, gynaecological) vs superficial (e.g. breast, head & neck, melanoma).
Exclusion criteria
- Patients not able to give informed consent
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL1497 |
| NTR-old | NTR1567 |
| Other | : |
| ISRCTN | ISRCTN wordt niet meer aangevraagd |